International consensus diagnostic criteria for neuromyelitis optica spectrum disordersDean M. Wingerchuk, Brian G. Weinshenker, Brenda Banwell et al.|Neurology|2015Cited by 4.6k
Ocrelizumab versus Placebo in Primary Progressive Multiple SclerosisXavier Montalbán, Jerry S. Wolinsky, Stephen L. Hauser et al.|New England Journal of Medicine|2016Cited by 1.9k
MOG encephalomyelitis: international recommendations on diagnosis and antibody testingSven Jarius, Brigitte Wildemann, Friedemann Paul et al.|Journal of Neuroinflammation|2018Cited by 740
Ofatumumab versus Teriflunomide in Multiple SclerosisStephen L. Hauser, Ludwig Kappos, Amit Bar‐Or et al.|New England Journal of Medicine|2020Cited by 706
Neuromyelitis Optica and Non–Organ-Specific AutoimmunitySean J. Pittock, Brian G. Weinshenker, Vanda A. Lennon et al.|Archives of Neurology|2008Cited by 612